Pliant Therapeutics Announces Upcoming Presentation Of Phase 1 Clinical Trial Of PLN-101095 In Patients With Solid Tumors At The 2026 Aacr Annual Meeting
March 18 (Reuters) - Pliant Therapeutics Inc PLRX.O:
PLIANT THERAPEUTICS ANNOUNCES UPCOMING PRESENTATION OF PHASE 1 CLINICAL TRIAL OF PLN-101095 IN PATIENTS WITH SOLID TUMORS AT THE 2026 AACR ANNUAL MEETING
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.